Atlas Trials

Trial of Plasma Exchange for Severe Crescentic IgA Nephropathy

Clinical trial NCT02647255 · TERMINATED

Trial details

NCT number
NCT02647255
Sponsor
Peking University First Hospital
Status
TERMINATED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Glomerulonephritis, IGAKidney DiseasesAcute Renal InsufficiencyRapidly Progressive Glomerulonephritis
Start date
2016-03-01
Primary completion
2020-10-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.